by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Bio Technology : October 2009
20 Australasian BioTechnology Volume 19 • Number 3 • October 2009 AusBioFEATURE --- AusBiotech 2009 Outline of the IP Manual The IP Manual addresses the aspects of IP management touched on in the scenarios above. The IP Manual is organised in sections aimed at particular stakeholders in the biotechnology sector (e.g. researchers, senior management, etc). Each chapter provides information and material relevant to each type of stakeholder to enable them to implement IP management best practices. The Manual includes a comprehensive treatment of the issues arising in identifying, protecting, managing and exploiting valuable IP. Wherever possible, checklists and other tools are included to provide 'hands on' assistance for users in their day-to-day activities. An outline of the content of the IP Manual is set out below: Chapter 1: Why is intellectual property important to your organisation Describes the importance of IP to stakeholders in the biotechnology industry. Chapter 2: What everyone should know Provides a basic introduction to intellectual property and the various forms of protection available. Chapter 3: What the board and CEO must know Describes the development and implementation of an IP strategy suitable for biotechnology organisations and the manner in which IP may be leveraged for capital raising. Chapter 4: What researchers must know Describes the importance of identifying IP at the research planning and implementation stage to reduce the risk of infringement and maximise the potential outcomes. Chapter 5: What managers making IP protection decisions must know Describes how to identify the different types of IP that arise and how best to put in place effective protection of that IP. Chapter 6: What senior management must know Describes how an IP policy may be integrated into the culture of an organisation, why appropriate contractual arrangements with staff and external providers are necessary, as well as covering IP audits and valuations. Chapter 7: What must be known about IP commercialisation Provides guidance to assist with decision-making on various issues of IP commercialisation, such as whether the IP is ready for commercialisation and, if so, under what commercialisation structure, as well as risks of IP commercialisation. Chapter 8: What must be known about enforcing and defending your IP Discusses issues that should be considered before commencing enforcement procedures, the defence of IP infringement allegations and provides an introduction to IP insurances. Chapter 9: Where can I fnd out more about IP? Provides a collection of useful references. Appendices, index and glossary of abbreviations For a copy of the Biotechnology Intellectual Property Management Manual visit: www.sprusons.com.au or collect one at the AusBiotech 2009 conference. Don't forget to register online at www.ausbiotech.org/events for the Smart IP Management Workshop to be held on Tuesday 27 October 2009 (the day prior to the 2009 AusBiotech Conference), at the Melbourne Convention Centre. Places are limited, so book now on www.ausbiotech.org/events to secure your spot in this highly practical and interactive session that will help you put the IP Manual into practice. Online registrations close COB 9 October 2009. Please note that the Manual is intended to provide general guidance on IP Management. For professional assistance with respect to the issues identified in the Manual and advice on how to implement 'best practice' IP management in your organisation please contact Spruson & Ferguson. Spruson & Ferguson is one of Australia's oldest and most experienced IP firms. In authoring the Manual, Spruson & Ferguson has drawn on its experience in its large biotechnology and IP commercialisation practices, as well as its experience in authoring previous IP manuals, including for the Australian Government.